AGENT FOR TREATING ASTHENIC SYNDROME IN PATIENTS WITH MULTIPLE SCLEROSIS Russian patent published in 2012 - IPC A61K36/57 A61K36/234 A61K36/41 A61K36/25 A61K36/254 A61K36/28 A61K35/12 A61P25/00 

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine, namely neurology, and is applicable for treating asthenic syndrome in the patients suffering multiple sclerosis. The agent contains mixed infusions of ginseng root of a true, schizandra seeds Chinese, Japanese angelica tree roots, devil's-club roots, snowdone rose roots, extracts of spiny eleuterococcus roots, Rhaponticum carthamoides roots and pantocrine taken in certain proportions.

EFFECT: agent show adaptogenic, polyglandular, including positive gonadotropic, tonic, bracing, immunomodulatory, metabolism-corrective, reparation and regeneration enhancing action; does not cause complications accompanying the long-time treatment, has no restrictions in the wide spectrum of neurologic and somatic diseases.

2 ex, 1 tbl